A novel Fe3O4/graphene oxide/citrus peel-derived bio-char based nanocomposite with enhanced adsorption affinity and sensitivity of ciprofloxacin and Sparfloxacin (cas 111542-93-9)
-
Add time:09/04/2019 Source:sciencedirect.com
To create more active adsorption sites on biochar, the Fe3O4/GO/citrus peel-derived magnetic bio-nanocomposite (mGOCP) with hierarchically porous architectures was synthesized by a facile one-pot hydrothermal approach for efficient removal of fluoroquinolone antibiotics ciprofloxacin (CIP) and sparfloxacin (SPA). The characterization analysis of bio-nanocomposites showed that the incorporation of GO could ensure relatively higher surface area (1556 cm2 g−1), more abundant pore structure, and higher thermal stability within mGOCP bio-nanocomposites than Fe3O4/citrus peel-derived magnetic bio-nanocomposites (mCP). And the mGOCP-1% attained outstanding adsorption capacity for CIP (283.44 mg g−1) and SPA (502.37 mg g−1), respectively. The primary adsorption mechanisms for CIP and SPA included π-π electron donor-acceptor interaction, H-bonding, hydrophobic interaction and electrostatic interaction. Overall, the surface morphology and structural composition of biochars could be regulated with GO to facilitate the adsorption capacity. Moreover, the developed mGOCP could be extended as a potential adsorbent for removal of other emerging organic pollutants in water.
We also recommend Trading Suppliers and Manufacturers of Sparfloxacin (cas 111542-93-9). Pls Click Website Link as below: cas 111542-93-9 suppliers
Prev:Phosphine derivatives of Sparfloxacin (cas 111542-93-9) – Synthesis, structures and in vitro activity
Next:Short communicationImpact of Sparfloxacin (cas 111542-93-9) on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP – An in vitro study) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleSimple and sensitive determination of Sparfloxacin (cas 111542-93-9) in pharmaceuticals and biological samples by immunoassay09/08/2019
- Cobalt(II) complexes of Sparfloxacin (cas 111542-93-9): Characterization, structure, antimicrobial activity and interaction with DNA and albumins09/07/2019
- Determination of Sparfloxacin (cas 111542-93-9) with CdSe/CdS quantum dots as fluorescent probes09/06/2019
- Short communicationImpact of Sparfloxacin (cas 111542-93-9) on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP – An in vitro study09/05/2019
- Phosphine derivatives of Sparfloxacin (cas 111542-93-9) – Synthesis, structures and in vitro activity09/03/2019
- Combined experimental and theoretical studies on the diorganotin(IV) complexes of Sparfloxacin (cas 111542-93-9): Synthesis, spectroscopic and DFT studies, and biological activity09/02/2019
- Sparfloxacin (cas 111542-93-9)09/01/2019


